Matches in Wikidata for { <http://www.wikidata.org/entity/Q51600613> ?p ?o ?g. }
- Q51600613 description "2016 nî lūn-bûn" @default.
- Q51600613 description "2016年の論文" @default.
- Q51600613 description "2016年学术文章" @default.
- Q51600613 description "2016年学术文章" @default.
- Q51600613 description "2016年学术文章" @default.
- Q51600613 description "2016年学术文章" @default.
- Q51600613 description "2016年学术文章" @default.
- Q51600613 description "2016年学术文章" @default.
- Q51600613 description "2016年學術文章" @default.
- Q51600613 description "2016年學術文章" @default.
- Q51600613 description "2016年學術文章" @default.
- Q51600613 description "2016年學術文章" @default.
- Q51600613 description "2016年學術文章" @default.
- Q51600613 description "2016년 논문" @default.
- Q51600613 description "article científic" @default.
- Q51600613 description "article scientific" @default.
- Q51600613 description "article scientifique" @default.
- Q51600613 description "articol științific" @default.
- Q51600613 description "articolo scientifico" @default.
- Q51600613 description "artigo científico" @default.
- Q51600613 description "artigo científico" @default.
- Q51600613 description "artigo científico" @default.
- Q51600613 description "artikel ilmiah" @default.
- Q51600613 description "artikull shkencor" @default.
- Q51600613 description "artikulong pang-agham" @default.
- Q51600613 description "artykuł naukowy" @default.
- Q51600613 description "artículo científico publicado en 2016" @default.
- Q51600613 description "artículu científicu" @default.
- Q51600613 description "bilimsel makale" @default.
- Q51600613 description "bài báo khoa học" @default.
- Q51600613 description "naučni članak" @default.
- Q51600613 description "scienca artikolo" @default.
- Q51600613 description "scientific article published on 31 July 2016" @default.
- Q51600613 description "scientific article published on 31 July 2016" @default.
- Q51600613 description "scientific article published on 31 July 2016" @default.
- Q51600613 description "teaduslik artikkel" @default.
- Q51600613 description "tieteellinen artikkeli" @default.
- Q51600613 description "tudományos cikk" @default.
- Q51600613 description "vedecký článok" @default.
- Q51600613 description "vetenskaplig artikel" @default.
- Q51600613 description "videnskabelig artikel" @default.
- Q51600613 description "vitenskapelig artikkel" @default.
- Q51600613 description "vitskapeleg artikkel" @default.
- Q51600613 description "vědecký článek" @default.
- Q51600613 description "wetenschappelijk artikel" @default.
- Q51600613 description "wissenschaftlicher Artikel" @default.
- Q51600613 description "επιστημονικό άρθρο" @default.
- Q51600613 description "мақолаи илмӣ" @default.
- Q51600613 description "наукова стаття, опублікована в липні 2016" @default.
- Q51600613 description "научна статия" @default.
- Q51600613 description "научная статья" @default.
- Q51600613 description "научни чланак" @default.
- Q51600613 description "научни чланак" @default.
- Q51600613 description "מאמר מדעי" @default.
- Q51600613 description "مقالة علمية نشرت في 31 يوليو 2016" @default.
- Q51600613 description "৩১ জুলাই ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q51600613 description "บทความทางวิทยาศาสตร์" @default.
- Q51600613 description "სამეცნიერო სტატია" @default.
- Q51600613 name "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 name "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 type Item @default.
- Q51600613 label "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 label "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 prefLabel "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 prefLabel "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 P1433 Q51600613-364BDB45-C23A-4293-8C51-41ACD18231F8 @default.
- Q51600613 P1476 Q51600613-7616327C-8B8B-466E-9018-CF1CA77CAEFD @default.
- Q51600613 P2093 Q51600613-7BE41B58-A72A-4FCB-9045-1D9BCE05D04E @default.
- Q51600613 P2093 Q51600613-B92F3401-28F5-4F56-B5C1-C81DAC667558 @default.
- Q51600613 P2860 Q51600613-21DAAFD2-BBFD-4CB0-9455-B6778418FFAB @default.
- Q51600613 P2860 Q51600613-61F3A807-C305-4178-BA7A-EC66D12CAFFF @default.
- Q51600613 P2860 Q51600613-C5FAC8F0-3609-4D86-8B4F-E9155C312FE8 @default.
- Q51600613 P2860 Q51600613-CC6D7463-78FC-40A6-9AB0-2040F63DCB51 @default.
- Q51600613 P2860 Q51600613-D3117B85-467F-483D-AC9E-852DFD74A4DA @default.
- Q51600613 P2860 Q51600613-DE209866-35C6-4A5C-BCDF-6498873537E8 @default.
- Q51600613 P304 Q51600613-C7661728-8C52-46A1-BBE6-633F9824EAE0 @default.
- Q51600613 P31 Q51600613-76575040-ec1f-461e-9404-ee8e9621d67b @default.
- Q51600613 P31 Q51600613-DC0A2655-F32F-4D9C-A47B-43667C450B47 @default.
- Q51600613 P356 Q51600613-A619FD61-215B-498C-BE1E-4C45C63FF46E @default.
- Q51600613 P433 Q51600613-C177FDDE-7042-46B0-AEEF-7E3B2E42CAE8 @default.
- Q51600613 P478 Q51600613-87D718D3-E3C5-4EAD-BF58-C47BABF9C058 @default.
- Q51600613 P577 Q51600613-67522C08-4C4C-4677-A67F-5BF2898FFF76 @default.
- Q51600613 P698 Q51600613-AE4F22C1-C136-434D-9030-9734CB01B497 @default.
- Q51600613 P356 JJW141 @default.
- Q51600613 P698 27481879 @default.
- Q51600613 P1433 Q15817379 @default.
- Q51600613 P1476 "Pharmacokinetics and Exposure-response Relationship of Golimumab in Patients with Moderately-to-severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT Induction and Maintenance Studies." @default.
- Q51600613 P2093 "Ann Gils" @default.
- Q51600613 P2093 "Iris Detrez" @default.
- Q51600613 P2860 Q34614211 @default.
- Q51600613 P2860 Q37523503 @default.
- Q51600613 P2860 Q38137614 @default.
- Q51600613 P2860 Q38151885 @default.
- Q51600613 P2860 Q40354796 @default.
- Q51600613 P2860 Q42107239 @default.
- Q51600613 P304 "1-2" @default.
- Q51600613 P31 Q13442814 @default.
- Q51600613 P31 Q871232 @default.
- Q51600613 P356 "10.1093/ECCO-JCC/JJW141" @default.
- Q51600613 P433 "1" @default.